Southwest Healthcare System Signs New Three-Year Managed Cybersecurity RPP Contract With CynergisTek Worth Over $600,000

Rhea-AI Summary

CynergisTek, Inc. (CTEK) announced a significant multi-year agreement to enhance cybersecurity for a southwest healthcare system with over 25 locations. The Resilience Partner Program (RPP) includes risk assessments, penetration testing, and advisory services aimed at improving the client’s cybersecurity posture. Selected over numerous competitors, this contract highlights the program's tailored approach and addresses the increasing demands for cybersecurity amid evolving threats. CEO Mac McMillan emphasized the investment in proactive cybersecurity measures as essential for strengthening resilience.

Positive

• Secured a six-figure, multi-year agreement with a major healthcare system.
• RPP includes comprehensive services like risk assessments and penetration testing.
• Chosen over multiple competitors, showcasing the program's competitive edge.
• Investment in cybersecurity is designed to build resilience and improve risk management.

Negative

• None.

CynergisTek’s Resilience Partner Program helps well-known healthcare system strengthen their cybersecurity defenses

AUSTIN, Texas--(BUSINESS WIRE)-- CynergisTek, Inc. (NYSE American: CTEK) (“CynergisTek”), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces it has signed a six-figure, multi-year Resilience Partner Program (RPP) agreement to provide cybersecurity risk assessments, penetration testing, technical assessments, medical device security, and advisory services to a southwest healthcare system with over 25 community locations.

CynergisTek’s Resilience Partner Program is designed to assist organizations with active risk management and instill a proactive approach to responding to cyber threats. The RPP provides this client with a valuable, independent, third-party review of its information security program and posture against the current threat landscape to uncover security vulnerabilities. CynergisTek’s team of highly experienced security and privacy resources helps prioritize risk, provide remediation guidance, formalize incident response protocols, and strengthen the overall program maturity.

“This client turned to CynergisTek for help in staying ahead of the constantly evolving threat landscape. With the ever-changing tools, techniques, and procedures of threat actors, there is increasing demand for CynergisTek’s strategic and tactical advantages that aid in averting compromise,” said Benjamin Denkers, CIO of CynergisTek.

“As we were selected over multiple competitors in a nationwide RFP process, this win highlights the value of the RPP and its unique, tailored approach to each client. This is a significant investment in multiple services designed to assist this client in strengthening its cybersecurity posture,” said Mac McMillan, CEO of CynergisTek. The RPP focuses on improving risk management and building resilience by including more proactive elements.

About CynergisTek, Inc.

CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This release contains certain forward-looking statements relating to the business of CynergisTek. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of CynergisTek’s vendors to continue supplying CynergisTek with supplies and services at comparable terms and prices; CynergisTek’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; CynergisTek’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; CynergisTek’s ability to retain key members of management and successfully integrate new executives; CynergisTek’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of the COVID-19 pandemic, including actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of the COVID-19 pandemic on CynergisTek, its customers and vendors, and on the global economy and financial markets; the general economic impact of the ongoing war in Ukraine, including the impact of related sanctions being imposed by the U.S. Government and the governments of other countries, and the impact of potential reprisals as a consequence of the war in Ukraine and any related sanctions; and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in CynergisTek’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry, or the ongoing war in Ukraine. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005257/en/

CynergisTek Investor Relations Contact:

CynergisTek, Inc.

Bryan Flynn

(512) 402-8550 x7

InvestorRelations@cynergistek.com         

CynergisTek Media Contact:

CynergisTek, Inc.

Lauren Frickle

(612) 806-0764 Ext. 7216

lauren.frickle@cynergistek.com 

Source: CynergisTek, Inc.